Structure

Physi-Chem Properties

Molecular Weight:  346.25
Volume:  387.78
LogP:  5.518
LogD:  4.059
LogS:  -4.878
# Rotatable Bonds:  6
TPSA:  35.53
# H-Bond Aceptor:  3
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.505
Synthetic Accessibility Score:  4.719
Fsp3:  0.682
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.705
MDCK Permeability:  1.9279306798125617e-05
Pgp-inhibitor:  0.99
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.844
30% Bioavailability (F30%):  0.031

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.158
Plasma Protein Binding (PPB):  90.50472259521484%
Volume Distribution (VD):  2.357
Pgp-substrate:  9.553471565246582%

ADMET: Metabolism

CYP1A2-inhibitor:  0.048
CYP1A2-substrate:  0.106
CYP2C19-inhibitor:  0.105
CYP2C19-substrate:  0.646
CYP2C9-inhibitor:  0.178
CYP2C9-substrate:  0.061
CYP2D6-inhibitor:  0.024
CYP2D6-substrate:  0.264
CYP3A4-inhibitor:  0.808
CYP3A4-substrate:  0.367

ADMET: Excretion

Clearance (CL):  3.103
Half-life (T1/2):  0.202

ADMET: Toxicity

hERG Blockers:  0.012
Human Hepatotoxicity (H-HT):  0.726
Drug-inuced Liver Injury (DILI):  0.321
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.019
Maximum Recommended Daily Dose:  0.968
Skin Sensitization:  0.732
Carcinogencity:  0.823
Eye Corrosion:  0.868
Eye Irritation:  0.91
Respiratory Toxicity:  0.969

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC233332

Natural Product ID:  NPC233332
Common Name*:   14,17-Epoxyloba-8,10,13(15)-Trien-18-Ol-18-Acetate
IUPAC Name:   2-[(2R)-5-[(1S,3R,4R)-4-ethenyl-4-methyl-3-prop-1-en-2-ylcyclohexyl]-3,6-dihydro-2H-pyran-2-yl]propan-2-yl acetate
Synonyms:  
Standard InCHIKey:  ASFMVDIIZYGBKO-RYTRXMBJSA-N
Standard InCHI:  InChI=1S/C22H34O3/c1-8-22(7)12-11-17(13-19(22)15(2)3)18-9-10-20(24-14-18)21(5,6)25-16(4)23/h8-9,17,19-20H,1-2,10-14H2,3-7H3/t17-,19+,20+,22-/m0/s1
SMILES:  C=C[C@@]1(C)CC[C@@H](C[C@@H]1C(=C)C)C1=CC[C@@H](OC1)C(OC(=O)C)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL511452
PubChem CID:   10569626
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids
          • [CHEMONTID:0002872] Elemane sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26994 Lobophytum pauciflorum Species Alcyoniidae Eukaryota n.a. n.a. n.a. PMID[22209732]
NPO26994 Lobophytum pauciflorum Species Alcyoniidae Eukaryota n.a. Mindoro, Philippines n.a. PMID[9548875]
NPO26994 Lobophytum pauciflorum Species Alcyoniidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT985 Organism Cladosporium cucumerinum Cladosporium cucumerinum IZ = 10.0 mm PMID[507681]
NPT985 Organism Cladosporium cucumerinum Cladosporium cucumerinum IZ = 8.0 mm PMID[507681]
NPT985 Organism Cladosporium cucumerinum Cladosporium cucumerinum IZ = 6.0 mm PMID[507681]
NPT176 Organism Artemia salina Artemia salina LC50 = 33.96 ug.mL-1 PMID[507681]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC233332 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9114 High Similarity NPC49208
0.8875 High Similarity NPC23748
0.8861 High Similarity NPC25554
0.8846 High Similarity NPC233295
0.8608 High Similarity NPC242767
0.8488 Intermediate Similarity NPC303697
0.8452 Intermediate Similarity NPC131329
0.8434 Intermediate Similarity NPC35933
0.8293 Intermediate Similarity NPC471218
0.8272 Intermediate Similarity NPC469802
0.8272 Intermediate Similarity NPC474592
0.8256 Intermediate Similarity NPC20946
0.8256 Intermediate Similarity NPC246028
0.8205 Intermediate Similarity NPC104644
0.8161 Intermediate Similarity NPC273199
0.814 Intermediate Similarity NPC473879
0.8095 Intermediate Similarity NPC96055
0.8068 Intermediate Similarity NPC177641
0.8046 Intermediate Similarity NPC177141
0.8046 Intermediate Similarity NPC82876
0.8025 Intermediate Similarity NPC184737
0.8023 Intermediate Similarity NPC245004
0.8023 Intermediate Similarity NPC166857
0.8 Intermediate Similarity NPC472442
0.8 Intermediate Similarity NPC474013
0.8 Intermediate Similarity NPC471795
0.7973 Intermediate Similarity NPC329698
0.7931 Intermediate Similarity NPC93411
0.7931 Intermediate Similarity NPC477128
0.7927 Intermediate Similarity NPC44083
0.7927 Intermediate Similarity NPC153987
0.7927 Intermediate Similarity NPC100906
0.7907 Intermediate Similarity NPC471219
0.7907 Intermediate Similarity NPC102996
0.7907 Intermediate Similarity NPC286153
0.7907 Intermediate Similarity NPC220478
0.7901 Intermediate Similarity NPC283619
0.7889 Intermediate Similarity NPC166143
0.7889 Intermediate Similarity NPC120351
0.7889 Intermediate Similarity NPC471994
0.7882 Intermediate Similarity NPC306951
0.7857 Intermediate Similarity NPC256112
0.7841 Intermediate Similarity NPC293044
0.7841 Intermediate Similarity NPC284561
0.7831 Intermediate Similarity NPC195424
0.7816 Intermediate Similarity NPC102640
0.7816 Intermediate Similarity NPC476600
0.7805 Intermediate Similarity NPC474005
0.7802 Intermediate Similarity NPC33473
0.7802 Intermediate Similarity NPC281134
0.7792 Intermediate Similarity NPC476945
0.7778 Intermediate Similarity NPC301525
0.7778 Intermediate Similarity NPC53555
0.7765 Intermediate Similarity NPC193198
0.7765 Intermediate Similarity NPC12283
0.7765 Intermediate Similarity NPC472440
0.7765 Intermediate Similarity NPC476927
0.7765 Intermediate Similarity NPC42476
0.7765 Intermediate Similarity NPC477124
0.7765 Intermediate Similarity NPC311070
0.7765 Intermediate Similarity NPC474193
0.7753 Intermediate Similarity NPC469595
0.7753 Intermediate Similarity NPC212679
0.7753 Intermediate Similarity NPC220454
0.7753 Intermediate Similarity NPC78973
0.7738 Intermediate Similarity NPC14203
0.7738 Intermediate Similarity NPC170303
0.7738 Intermediate Similarity NPC229584
0.7738 Intermediate Similarity NPC142163
0.7738 Intermediate Similarity NPC108476
0.7727 Intermediate Similarity NPC106332
0.7727 Intermediate Similarity NPC69713
0.7727 Intermediate Similarity NPC24816
0.7701 Intermediate Similarity NPC329692
0.7701 Intermediate Similarity NPC118266
0.7692 Intermediate Similarity NPC104925
0.7692 Intermediate Similarity NPC469491
0.7692 Intermediate Similarity NPC472360
0.7692 Intermediate Similarity NPC88507
0.7692 Intermediate Similarity NPC472416
0.7692 Intermediate Similarity NPC298973
0.7692 Intermediate Similarity NPC469697
0.7692 Intermediate Similarity NPC38830
0.7684 Intermediate Similarity NPC11956
0.7683 Intermediate Similarity NPC40049
0.7683 Intermediate Similarity NPC470751
0.7683 Intermediate Similarity NPC189206
0.7683 Intermediate Similarity NPC470750
0.7674 Intermediate Similarity NPC318515
0.7667 Intermediate Similarity NPC49420
0.7667 Intermediate Similarity NPC234335
0.7667 Intermediate Similarity NPC477574
0.766 Intermediate Similarity NPC473510
0.766 Intermediate Similarity NPC38855
0.7647 Intermediate Similarity NPC471159
0.7647 Intermediate Similarity NPC123880
0.7647 Intermediate Similarity NPC471408
0.764 Intermediate Similarity NPC261320
0.764 Intermediate Similarity NPC473647
0.7634 Intermediate Similarity NPC125551
0.7634 Intermediate Similarity NPC239547
0.7634 Intermediate Similarity NPC155319
0.7634 Intermediate Similarity NPC473244
0.7634 Intermediate Similarity NPC96597
0.7634 Intermediate Similarity NPC309503
0.7634 Intermediate Similarity NPC210337
0.7634 Intermediate Similarity NPC91197
0.7619 Intermediate Similarity NPC268827
0.7619 Intermediate Similarity NPC474739
0.7619 Intermediate Similarity NPC269791
0.7614 Intermediate Similarity NPC471796
0.7609 Intermediate Similarity NPC472189
0.7609 Intermediate Similarity NPC471362
0.7609 Intermediate Similarity NPC471372
0.7609 Intermediate Similarity NPC276110
0.7604 Intermediate Similarity NPC23584
0.7595 Intermediate Similarity NPC469660
0.759 Intermediate Similarity NPC264610
0.7586 Intermediate Similarity NPC189311
0.7582 Intermediate Similarity NPC7349
0.7579 Intermediate Similarity NPC472554
0.7558 Intermediate Similarity NPC132386
0.7558 Intermediate Similarity NPC474809
0.7558 Intermediate Similarity NPC22611
0.7558 Intermediate Similarity NPC222358
0.7556 Intermediate Similarity NPC220216
0.7556 Intermediate Similarity NPC469372
0.7556 Intermediate Similarity NPC302280
0.7556 Intermediate Similarity NPC310479
0.7556 Intermediate Similarity NPC182136
0.7553 Intermediate Similarity NPC98868
0.7532 Intermediate Similarity NPC185587
0.7531 Intermediate Similarity NPC475517
0.7531 Intermediate Similarity NPC474524
0.7531 Intermediate Similarity NPC71152
0.7529 Intermediate Similarity NPC195334
0.7529 Intermediate Similarity NPC290495
0.7529 Intermediate Similarity NPC327002
0.7529 Intermediate Similarity NPC159148
0.7529 Intermediate Similarity NPC476101
0.7528 Intermediate Similarity NPC215831
0.7528 Intermediate Similarity NPC226863
0.7527 Intermediate Similarity NPC221801
0.7527 Intermediate Similarity NPC162346
0.7527 Intermediate Similarity NPC311166
0.7527 Intermediate Similarity NPC284194
0.7527 Intermediate Similarity NPC171598
0.7527 Intermediate Similarity NPC471765
0.7527 Intermediate Similarity NPC88009
0.7527 Intermediate Similarity NPC57664
0.7527 Intermediate Similarity NPC211810
0.75 Intermediate Similarity NPC471537
0.75 Intermediate Similarity NPC325869
0.75 Intermediate Similarity NPC477129
0.75 Intermediate Similarity NPC140277
0.75 Intermediate Similarity NPC105490
0.75 Intermediate Similarity NPC175145
0.75 Intermediate Similarity NPC264127
0.75 Intermediate Similarity NPC475069
0.75 Intermediate Similarity NPC477130
0.75 Intermediate Similarity NPC472552
0.75 Intermediate Similarity NPC477084
0.75 Intermediate Similarity NPC131813
0.7474 Intermediate Similarity NPC230546
0.7474 Intermediate Similarity NPC227865
0.7473 Intermediate Similarity NPC329842
0.7473 Intermediate Similarity NPC124374
0.7471 Intermediate Similarity NPC102048
0.747 Intermediate Similarity NPC476439
0.747 Intermediate Similarity NPC132542
0.7468 Intermediate Similarity NPC269841
0.7468 Intermediate Similarity NPC101622
0.7468 Intermediate Similarity NPC329656
0.7447 Intermediate Similarity NPC472188
0.7447 Intermediate Similarity NPC110937
0.7447 Intermediate Similarity NPC202705
0.7447 Intermediate Similarity NPC73911
0.7447 Intermediate Similarity NPC98112
0.7444 Intermediate Similarity NPC470734
0.7444 Intermediate Similarity NPC50488
0.7444 Intermediate Similarity NPC474396
0.7444 Intermediate Similarity NPC73995
0.7442 Intermediate Similarity NPC286786
0.7442 Intermediate Similarity NPC16321
0.7442 Intermediate Similarity NPC2524
0.7442 Intermediate Similarity NPC200513
0.7442 Intermediate Similarity NPC178676
0.7442 Intermediate Similarity NPC155521
0.7439 Intermediate Similarity NPC113639
0.7436 Intermediate Similarity NPC474477
0.7436 Intermediate Similarity NPC472266
0.7423 Intermediate Similarity NPC297617
0.7419 Intermediate Similarity NPC476519
0.7416 Intermediate Similarity NPC471779
0.7416 Intermediate Similarity NPC171722
0.7416 Intermediate Similarity NPC476948
0.7416 Intermediate Similarity NPC125925
0.7416 Intermediate Similarity NPC312561
0.7416 Intermediate Similarity NPC128644
0.7416 Intermediate Similarity NPC473891

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC233332 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7841 Intermediate Similarity NPD6051 Approved
0.7442 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD5325 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD8039 Approved
0.7191 Intermediate Similarity NPD1694 Approved
0.7188 Intermediate Similarity NPD4225 Approved
0.7179 Intermediate Similarity NPD2685 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD5330 Approved
0.7111 Intermediate Similarity NPD6409 Approved
0.7111 Intermediate Similarity NPD7146 Approved
0.7111 Intermediate Similarity NPD7521 Approved
0.7111 Intermediate Similarity NPD7334 Approved
0.7111 Intermediate Similarity NPD6684 Approved
0.701 Intermediate Similarity NPD7638 Approved
0.6957 Remote Similarity NPD6903 Approved
0.6957 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6939 Remote Similarity NPD7640 Approved
0.6939 Remote Similarity NPD6648 Approved
0.6939 Remote Similarity NPD7639 Approved
0.6916 Remote Similarity NPD7115 Discovery
0.6889 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6869 Remote Similarity NPD5344 Discontinued
0.6842 Remote Similarity NPD6399 Phase 3
0.6774 Remote Similarity NPD6672 Approved
0.6774 Remote Similarity NPD5737 Approved
0.6744 Remote Similarity NPD6933 Approved
0.6739 Remote Similarity NPD6098 Approved
0.6737 Remote Similarity NPD7637 Suspended
0.6737 Remote Similarity NPD5693 Phase 1
0.6706 Remote Similarity NPD6926 Approved
0.6706 Remote Similarity NPD6924 Approved
0.6667 Remote Similarity NPD3573 Approved
0.6667 Remote Similarity NPD7524 Approved
0.6635 Remote Similarity NPD6686 Approved
0.6632 Remote Similarity NPD7838 Discovery
0.6628 Remote Similarity NPD7339 Approved
0.6628 Remote Similarity NPD8264 Approved
0.6628 Remote Similarity NPD6942 Approved
0.6598 Remote Similarity NPD7748 Approved
0.6598 Remote Similarity NPD7900 Approved
0.6598 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6593 Remote Similarity NPD6695 Phase 3
0.6591 Remote Similarity NPD7322 Clinical (unspecified phase)
0.6562 Remote Similarity NPD6411 Approved
0.6552 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6526 Remote Similarity NPD6904 Approved
0.6526 Remote Similarity NPD6673 Approved
0.6526 Remote Similarity NPD6080 Approved
0.6522 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6522 Remote Similarity NPD4786 Approved
0.6518 Remote Similarity NPD7503 Approved
0.6517 Remote Similarity NPD7645 Phase 2
0.6512 Remote Similarity NPD4784 Approved
0.6512 Remote Similarity NPD4785 Approved
0.65 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6495 Remote Similarity NPD5778 Approved
0.6495 Remote Similarity NPD5779 Approved
0.6484 Remote Similarity NPD5209 Approved
0.6484 Remote Similarity NPD3667 Approved
0.6465 Remote Similarity NPD4792 Clinical (unspecified phase)
0.6458 Remote Similarity NPD6698 Approved
0.6458 Remote Similarity NPD46 Approved
0.6458 Remote Similarity NPD5207 Approved
0.6444 Remote Similarity NPD7514 Phase 3
0.6444 Remote Similarity NPD6931 Approved
0.6444 Remote Similarity NPD7332 Phase 2
0.6444 Remote Similarity NPD6930 Phase 2
0.6444 Remote Similarity NPD7525 Registered
0.6421 Remote Similarity NPD5208 Approved
0.64 Remote Similarity NPD7902 Approved
0.64 Remote Similarity NPD6083 Phase 2
0.64 Remote Similarity NPD6084 Phase 2
0.6396 Remote Similarity NPD7328 Approved
0.6396 Remote Similarity NPD7327 Approved
0.6392 Remote Similarity NPD7515 Phase 2
0.6392 Remote Similarity NPD5694 Approved
0.6392 Remote Similarity NPD6050 Approved
0.6381 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6372 Remote Similarity NPD8033 Approved
0.6364 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6364 Remote Similarity NPD5695 Phase 3
0.6354 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6354 Remote Similarity NPD6101 Approved
0.6353 Remote Similarity NPD7143 Approved
0.6353 Remote Similarity NPD7144 Approved
0.6344 Remote Similarity NPD3668 Phase 3
0.6339 Remote Similarity NPD7516 Approved
0.6333 Remote Similarity NPD6929 Approved
0.6333 Remote Similarity NPD4195 Approved
0.6316 Remote Similarity NPD7750 Discontinued
0.6316 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6311 Remote Similarity NPD7632 Discontinued
0.6292 Remote Similarity NPD6932 Approved
0.6289 Remote Similarity NPD5692 Phase 3
0.6289 Remote Similarity NPD5785 Approved
0.6283 Remote Similarity NPD8377 Approved
0.6283 Remote Similarity NPD8294 Approved
0.6279 Remote Similarity NPD7152 Approved
0.6279 Remote Similarity NPD7150 Approved
0.6279 Remote Similarity NPD7151 Approved
0.6279 Remote Similarity NPD4243 Approved
0.6277 Remote Similarity NPD6082 Clinical (unspecified phase)
0.6277 Remote Similarity NPD1733 Clinical (unspecified phase)
0.6264 Remote Similarity NPD4821 Approved
0.6264 Remote Similarity NPD4819 Approved
0.6264 Remote Similarity NPD7509 Discontinued
0.6264 Remote Similarity NPD4822 Approved
0.6264 Remote Similarity NPD4820 Approved
0.6264 Remote Similarity NPD5790 Clinical (unspecified phase)
0.6262 Remote Similarity NPD4061 Clinical (unspecified phase)
0.625 Remote Similarity NPD1145 Discontinued
0.6239 Remote Similarity NPD8297 Approved
0.6239 Remote Similarity NPD6053 Discontinued
0.6237 Remote Similarity NPD5362 Discontinued
0.6237 Remote Similarity NPD7154 Phase 3
0.6235 Remote Similarity NPD6923 Approved
0.6235 Remote Similarity NPD6922 Approved
0.6228 Remote Similarity NPD8378 Approved
0.6228 Remote Similarity NPD8296 Approved
0.6228 Remote Similarity NPD8380 Approved
0.6228 Remote Similarity NPD8335 Approved
0.6228 Remote Similarity NPD8379 Approved
0.6222 Remote Similarity NPD7145 Approved
0.6222 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6211 Remote Similarity NPD4623 Approved
0.6211 Remote Similarity NPD4519 Discontinued
0.6204 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6196 Remote Similarity NPD6902 Approved
0.6176 Remote Similarity NPD5696 Approved
0.617 Remote Similarity NPD3665 Phase 1
0.617 Remote Similarity NPD3666 Approved
0.617 Remote Similarity NPD3133 Approved
0.6168 Remote Similarity NPD6881 Approved
0.6168 Remote Similarity NPD6899 Approved
0.6168 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6147 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6139 Remote Similarity NPD5349 Clinical (unspecified phase)
0.6132 Remote Similarity NPD6675 Approved
0.6132 Remote Similarity NPD7128 Approved
0.6132 Remote Similarity NPD5739 Approved
0.6132 Remote Similarity NPD6008 Approved
0.6132 Remote Similarity NPD6402 Approved
0.6111 Remote Similarity NPD5776 Phase 2
0.6111 Remote Similarity NPD6925 Approved
0.6105 Remote Similarity NPD6893 Approved
0.6105 Remote Similarity NPD7520 Clinical (unspecified phase)
0.61 Remote Similarity NPD6001 Approved
0.61 Remote Similarity NPD5707 Approved
0.6075 Remote Similarity NPD5697 Approved
0.6064 Remote Similarity NPD5331 Approved
0.6064 Remote Similarity NPD5332 Approved
0.6061 Remote Similarity NPD8034 Phase 2
0.6061 Remote Similarity NPD7983 Approved
0.6061 Remote Similarity NPD8035 Phase 2
0.6061 Remote Similarity NPD5281 Approved
0.6061 Remote Similarity NPD7087 Discontinued
0.6061 Remote Similarity NPD5284 Approved
0.6061 Remote Similarity NPD6079 Approved
0.6058 Remote Similarity NPD4159 Approved
0.6055 Remote Similarity NPD7290 Approved
0.6055 Remote Similarity NPD6883 Approved
0.6055 Remote Similarity NPD6371 Approved
0.6055 Remote Similarity NPD7102 Approved
0.6044 Remote Similarity NPD4268 Approved
0.6044 Remote Similarity NPD4271 Approved
0.6042 Remote Similarity NPD3618 Phase 1
0.604 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6022 Remote Similarity NPD6898 Phase 1
0.6022 Remote Similarity NPD4790 Discontinued
0.6022 Remote Similarity NPD5369 Approved
0.602 Remote Similarity NPD1695 Approved
0.602 Remote Similarity NPD7285 Clinical (unspecified phase)
0.602 Remote Similarity NPD5328 Approved
0.6019 Remote Similarity NPD7320 Approved
0.6019 Remote Similarity NPD6011 Approved
0.6018 Remote Similarity NPD4198 Discontinued
0.6017 Remote Similarity NPD7507 Approved
0.6 Remote Similarity NPD8130 Phase 1
0.6 Remote Similarity NPD6869 Approved
0.6 Remote Similarity NPD6650 Approved
0.6 Remote Similarity NPD6617 Approved
0.6 Remote Similarity NPD6649 Approved
0.6 Remote Similarity NPD6847 Approved
0.5978 Remote Similarity NPD6683 Phase 2
0.5976 Remote Similarity NPD4194 Approved
0.5976 Remote Similarity NPD368 Approved
0.5976 Remote Similarity NPD4193 Approved
0.5976 Remote Similarity NPD4192 Approved
0.5976 Remote Similarity NPD4191 Approved
0.5963 Remote Similarity NPD6013 Approved
0.5963 Remote Similarity NPD6012 Approved
0.5963 Remote Similarity NPD6373 Approved
0.5963 Remote Similarity NPD6372 Approved
0.5963 Remote Similarity NPD6014 Approved
0.5957 Remote Similarity NPD4221 Approved
0.5957 Remote Similarity NPD4269 Approved
0.5957 Remote Similarity NPD4223 Phase 3
0.5957 Remote Similarity NPD4270 Approved
0.5946 Remote Similarity NPD6882 Approved
0.5938 Remote Similarity NPD5329 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data